Breast imaging in Canada has come a long way since organized screening for breast cancer began in 1988. The female breast cancer mortality rate has been declining since the 1990s, and it is now the lowest it has been since 1950 [1] . Mammography screening accounts for a substantial portion of the progressive mortality reduction.
In most general radiology practices, mammography accounts for at least 10% of all examinations performed. Yet mammographic interpretation is one of the most difficult tasks in all of radiology. Breast cancer has a varied appearance on mammograms, from the obvious spiculated masses, to very subtle asymmetries noted on only one view, to faint calcifications seen only with full digital resolution or a magnifying glass. It is not surprising that approximately 20% of cancers are known to be missed at mammography [2] . The allegation of delay in diagnosis of breast cancer continues to be the leading cause of malpractice litigation lodged against all physicians in the United States [3] . For these reasons and many others, the quality of mammographic imaging and interpretation becomes crucial.
In a special issue such as this, it is extremely tempting to try to present the newest innovations that are not yet ''household names.'' There are many promising techniques in the field of breast imaging, to mention a few: digital breast tomosynthesis, automated whole-breast sonography, breast magnetic resonance spectroscopy, diffusion-weighted imaging, optical imaging, elastography. However, in the everyday world of clinical radiology, no matter what the setting is, practitioners need to know basic differential diagnosis and to have an understanding of how to best use the equipment they already have. Therefore, we have elected to bring to you a series of excellent articles that span routinely used modalities and techniques and common clinical scenarios in breast imaging.
One of the most controversial topics in the management of breast disease is the use of preoperative breast magnetic resonance imaging (MRI) in women with newly diagnosed breast carcinoma. Causer [4] provides an excellent review that highlights the yield of MRI and dissects previously reported data. Her analysis is important to share with our clinical colleagues.
Next, we present articles that aim to avoid errors that lead to the delay in diagnosis of breast carcinoma. Roberts-Klein et al [5] provide recommendations on how to avoid pitfalls in mammographic interpretation. Park et al [6] discuss reasons and solutions for missing and misinterpreting lesions in breast ultrasound. Furthermore, Kornecki [7] describes the current use of breast ultrasound in both diagnostic and screening settings.
In the 21st century, the preferred method of diagnosis for almost all breast lesions is imaging-guided core needle biopsy rather than surgery. Park et al [8] present technical problems and solutions for the 2 most widely used procedures: stereotactic and ultrasound-guided core biopsies. MRI-guided breast biopsy is a relatively new procedure that is an essential part of breast MRI service, but it is not yet widely implemented. Combined expertise on MRI-guided breast biopsy is presented by Price and Morris [9] from the world's largest breast MRI service at Memorial SloanKettering Cancer Center. We are certain that their tips and tricks will be avidly read by those who plan to begin doing MRI-guided breast biopsies and those who already do it.
In these days, many women choose to have reconstructive surgery after breast cancer treatment or after prophylactic mastectomy. Scaranelo et al [10] present a comprehensive review on imaging approaches and imaging findings for the variety of breast reconstruction options.
Breast imaging is the most strictly regulated field in radiology. Panu and Morris's [11] guiding article on establishing breast MRI service in the community hospital will be helpful to everyone who wants to fulfill American College of Radiology guidelines for the performance of breast MRI [12] .
